Skip to main content

Table 2 Prevalence of MAFLD in four groups according to AIP quartile in patients with T2D

From: Atherogenic index of plasma is an independent predictor of metabolic-associated fatty liver disease in patients with type 2 diabetes

AIP quartile

Non-MAFLD

MAFLD

P-value

1.00 (−0.53, 0.3760)

461

169

 < 0.001

73.2%

26.8%

2.00 (0.3761, 0.5384)

449

174

 < 0.001

72.1%

27.9%

3.00 (0.5385, 0.7117)

395

224

 < 0.001

63.8%

36.2%

4.00 (0.7118, 1.53)

382

237

 < 0.001

61.7%

38.3%

  1. AIP atherogenic index of plasma, MAFLD metabolic-associated fatty liver disease
Back to article page

European Journal of Medical Research

ISSN: 2047-783X

Contact us